GSA Capital Partners’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
Other funds holding ABUS
GSA Capital Partners's ABUS Position: Q3 2026 in Review
GSA Capital Partners increased its Arbutus Biopharma (ABUS) stake by 681% in Q3 2026, buying an estimated $1.45M and bringing the position to 344,290 shares worth $1.65M. The position accounts for 0.1% of the portfolio, ranked #266.
GSA Capital Partners first reported a position in ABUS in Q4 2020 and has held it in 10 quarters since. 216 funds tracked by Wall St. Rank hold ABUS as of Q3 2026.
- GSA Capital Partners held 344,290 shares of Arbutus Biopharma worth $1.65M as of Q3 2026.
- GSA Capital Partners bought 300,208 Arbutus Biopharma shares in Q3 2026, an estimated $1.45M.
- Arbutus Biopharma made up 0.1% of GSA Capital Partners's portfolio in Q3 2026, its #266 holding.
- GSA Capital Partners first reported a position in Arbutus Biopharma in Q4 2020 and has held it in 10 quarters since.
- 216 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2026.
Based on GSA Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.